Trials / Completed
CompletedNCT02333643
A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.
A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Study to Evaluate Efficacy and Safety of Topical Ionic Contra-viral Therapy (ICVT) Comprised of CLS003 in Cutaneous Warts
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- Maruho Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A phase 2, randomized, vehicle-controlled, double-blind study to assess the efficacy, safety and pharmacodynamics (PD) of topically applied CLS003 in otherwise healthy patients with cutaneous warts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CLS003 | |
| DRUG | Furosemide | |
| DRUG | Digoxin | |
| DRUG | Vehicle topical |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2015-01-07
- Last updated
- 2016-07-28
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02333643. Inclusion in this directory is not an endorsement.